✦ LIBER ✦

Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial

✍ Scribed by Joel M. Kaufman; Raymond C. Rosen; Ramagopal V. Mudumbi; Fisseha Tesfaye; Ron Hashmonay; David Rivas

Book ID: 109055468
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 244 KB
Volume: 103
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.08165.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Perceived control over ejaculation is ce

Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine

✍ Ridwan Shabsigh; Donald L. Patrick; David L. Rowland; Scott A. Bull; Fisseha Tes 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

PSD502 improves ejaculatory latency, con

PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study

✍ W. Wallace Dinsmore; Michael G. Wyllie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

A double-blind, placebo-controlled, rand

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

✍ Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora G 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 210 KB

Photodynamic therapy with BF-200 ALA for

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

✍ R.-M. Szeimies; P. Radny; M. Sebastian; F. Borrosch; T. Dirschka; G. Krähn-Senft 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

A placebo-controlled double blind trial

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome : Results from N00C1 from the North Central Cancer Treatment Group

✍ Aminah Jatoi; Shaker R. Dakhil; Phuong L. Nguyen; Jeff A. Sloan; John W. Kugler; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## BACKGROUND. Tumor necrosis factor‐α (TNF‐α) is a putative mediator of the cancer anorexia/weight loss syndrome. The current study was designed to determine whether etanercept (a dimeric fusion protein consisting of the extracellular ligand‐binding portion of the human 75‐kilodalton

Solifenacin in the treatment of urgency

Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial

✍ Linda Cardozo; Elke Heßdörfer; Rodolfo Milani; Pedro Arañó; Luc Dewilde; Mark Sl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB